Lilis Medical is an African-led health research and scientific advisory firm focused on generating evidence, strengthening health ecosystems, and translating research into sustainable impact.
We work at the intersection of clinical research governance, implementation science, health ecosystems and Evidence-to-Implementation Research (EIR™) to help organizations understand whether innovations are ready to move from evidence into real-world use.
The platform deploys prospective Health Ecosystem Readiness Assessments and utilizes the Innovation Translation Pathway™ to evaluate the baseline absorption capacity of localized health networks. By analyzing multi-tiered health financing variables, provider-level workflows, and data systems, Lilis Medical provides global health stakeholders, pharmaceutical sponsors, and life-science developers with a standardized risk-mitigation framework to secure long-term care continuity and post-project sustainability horizons in low- and middle-income countries.
Lilis Medical works at the intersection of research, health ecosystems and implementation We help organizations generate robust evidence, assess readiness for innovation absorption and adoption, and translate research into sustainable real-world impact.
Our work brings together clinical research governance, implementation science, health-ecosystem thinking and our Evidence-to-Implementation Research (EIR™) methodology.
Evidence-to-Implementation Research (EIR™)
Lilis Medical developed EIR™ as a structured methodology for prospectively assessing whether the conditions required for evidence and innovation to move into routine, sustainable real-world use exist within the receiving health ecosystem.
Rather than beginning with implementation activities, EIR™ assesses readiness across the interconnected conditions that influence the absorption, adoption, adaptation and sustained integration of evidence-informed innovations.
EIR™ complements implementation science by helping identify and strengthen the enabling conditions for sustainable implementation before implementation begins.
Clinical Research Governance
Clinical research oversight, research quality, data integrity, regulatory considerations and evidence generation across global health settings.
Implementation Science
Applied research examining the organizational, health-ecosystem, community and contextual conditions that influence adoption, adaptation, integration and sustainability.
Health Policy & Ecosystem Analysis
Analysis of health-ecosystem, policy, governance and institutional conditions that shape the translation of evidence into routine practice.
Evidence-to-Implementation Research (EIR™)
Prospective assessment of health-ecosystem readiness to support the absorption, adoption, adaptation and sustained integration of evidence-informed innovations.
Dr. Lulu Nyawira Oguda · 2026
Service and Collaboration Pillars
Lilis Medical welcomes structured collaborations with global life-sciences corporations, research networks, and international development sponsors to support evidence translation and health innovation introduction across Africa. We offer targeted advisory across three clinical and scientific pillars:
Prospective Ecosystem Readiness Assessment: Mapping the granular clinical conditions, frontline workforce workflows, and facility-level absorption capacities required to safely introduce complex biomedical innovations.
Clinical Research Governance & RWE Strategy: Guiding the design of multi-country research protocols, observational registries, and Real-World Evidence (RWE) models aligned with internationally recognized ALCOA+ data integrity principles.
Coordinated Care Pathway Design: Evaluating systemic bottlenecks across the clinical care continuum—spanning from screening and acute management through to longitudinal follow-up—to ensure long-term care continuity.